AVR-48 improves respiratory function and alveolar development in a preterm lamb model of Bronchopulmonary Dysplasia (BPD)
Saturday, April 23, 2022
1:45 PM – 2:00 PM US MT
Location: Convention Center: Mile High Ballroom 4AB
CE: Enduring CME: 0.25
Publication Number: 1555.4
David Riley, Texas Christian University and UNT Health Science Center School of Medicine, Fort Worth, TX, United States; Dale J. Christensen, Duke University School of Medicine, Cary, NC, United States; Russell L. Bromley, Ayuvis Research, Inc., Corinth, TX, United States; Andrew Rebentisch, University of Utah - division of neonatology, Salt Lake City, UT, United States; Elaine Dawson, University of Utah, Newport Beach, CA, United States; Jakob D. Van Boerum, University of Utah, Holladay, UT, United States; Emily Major, University of Utah, Salt Lake City, UT, United States; Kurt H. Albertine, University of Utah School of Medicine, Salt Lake City, UT, United States; Suchismita Acharya, AyuVis Research Inc, Fort Worth, TX, United States
Presenting Author(s)
David Riley, MD, MBA
Assistant Professor Texas Christian University and UNT Health Science Center School of Medicine Fort Worth, Texas, United States
Russell L. Bromley, BA: ● AyuVis Research, Inc. (Currently Ongoing) (Products/Services: Contractor including contracted research, Consultant).
Andrew Rebentisch, None: ● AyuVis Research (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Takeda Pharmaceuticals (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● United Therapeutics and Boston Children's Hospital (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Elaine Dawson, BS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jakob D. Van Boerum: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Emily Major: ● AyuVis Research, Inc. (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Takeda Pharmaceuticals (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● United Therapeutics and Boston Children's Hospital (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Kurt H. Albertine, PhD, FAAAS, FAAA: ● AyuVis Research, Inc. (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Takeda Pharmaceuticals (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● United Therapeutics and Boston Children's Hospital (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Suchismita Acharya, PhD: ● AyuVis Research Inc (Currently Ongoing) (Products/Services: Board Member or Executive Role, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
